Properties |
Information |
PhytoCAT-ID |
PhytoCAT-1180 |
Phytochemical name or plant extracts |
Schisandrin B |
PMID |
28827665 |
Literature evidence |
Our results showed that Sch B increased the intracellular accumulation of DOX through inhibiting expression and activity of P-glycoprotein (P-gp). |
IUPAC name |
3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene |
Phytochemicals’ class or type of plant extracts |
Lignan |
Source of phytochemicals or plant Extracts |
Schisandrae Chinensis |
|
Geographical availability |
Amur, China North-Central, Inner Mongolia, Japan, Khabarovsk, Korea, Manchuria, Primorye, Sakhalin |
Plant parts |
NA |
Other cancers |
Breast cancer, Cervical cancer |
Target gene or protein |
NOX4, TGF-β |
Gene or Protein evidence |
Sch B suppresses TGF-β-induced and NOX4-associated ROS production in 4T1 cells and inhibits TGF-β-enhanced cell migration. |
Target pathways |
NA |
IC50 |
NA |
Potency |
Meanwhile, Sch B was identified as a potent P-gp inhibitor and could enhance DOX-induced apoptosis in cancer cells, but not in primary rat
cardiomyocytes and primary human fibroblasts |
Cell line/ mice model |
4T1, siha, MCF-7, A2780 |
Additional information |
Furthermore, Sch B preferentially promoted chymotryptic activity of the proteasome in a concentration-dependent manner, and the proteasome inhibitor MG-132 prevented Sch B-induced survivin downregulation.
Taken together, our findings suggest that Sch B could be a potential candidate for combating drug resistant cancer via modulating two key factors that responsible for cancer resistance. |
PubChem ID |
108130 |
Additional PMIDs |
28827665 23688500 |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:60456331-2 |
Safety |
Schisandrin B (Sch B), a naturally occurring dibenzocyclooctadiene lignan with very low toxicity, is a novel NOX inhibitor and its IC50 toward NOX4 is 9.3μM |